Natus Medical Inc (BABY) 40.44 $BABY SmarTrend Watching

New Post Public Reply Private Reply Replies (0) Message Board

Jul 12, 2016 at 4:24 AM

Natus Medical Inc (BABY) 40.44 $BABY

SmarTrend Watching for Potential Pullback in Shares of Natus Medical After 3.52% Gain
Comtex SmarTrend(R) - Tue Jun 28, 3:09PM CDT
Natus Medical (NASDAQ:BABY) traded in a range yesterday that spanned from a low of $35.90 to a high of $37.43. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $36.66 on volume of 216,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BABY: 40.44 (+0.79)

IRADIMED CORPORATION Announces Appointment of Jonathan Kennedy to its Board of Directors
GlobeNewswire - Tue Jun 28, 3:00PM CDT
IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Jonathan Kennedy has been appointed to the Company's Board of Directors.
BABY: 40.44 (+0.79), IRMD: 21.75 (-0.38), ISIL: 14.04 (+0.06)

Natus Medical Expands Share Repurchase Program by $20M
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:54AM CDT
Natus Medical Inc. (BABY) recently announced an expansion of its share repurchase program, which authorizes it to buy back additional shares worth $20 million by Jun 1, 2017.
BABY: 40.44 (+0.79), MASI: 52.45 (+0.12), EXAC: 27.35 (+0.23), CRY: 12.19 (-0.04)

Natus Announces $20 Million Share Repurchase Program
GlobeNewswire - Fri Jun 03, 6:00AM CDT
Natus Medical Incorporated (NASDAQ:BABY) announced that its Board of Directors has approved an expansion of its existing stock repurchase program, authorizing the repurchase of up to an additional $20 million of the Company's common stock. The expiration date is set for June 1, 2017.
BABY: 40.44 (+0.79)

Natus to Present at Jefferies 2016 Healthcare Conference
GlobeNewswire - Wed Jun 01, 6:00AM CDT
Natus Medical Incorporated (NASDAQ:BABY) today announced that Jim Hawkins, President and Chief Executive Officer, will present at the Jefferies 2016 Healthcare Conference in New York City. Mr. Hawkins is scheduled to present at 3:30 p.m. EDT on Thursday, June 9, 2016.
BABY: 40.44 (+0.79)

Lifshitz & Miller Law Firm Announces Investigation of Amaya, Inc., Chiasma, Inc., Intrexon Corporation, Natus Medical Inc., NRG Yield, Inc., Sunrun Inc., TransEnterix and Vivint Solar, Inc.
PR Newswire - Mon May 09, 7:47PM CDT
Amaya, Inc. (AYA)
BABY: 40.44 (+0.79), RUN: 5.09 (+0.01), XON: 26.23 (-0.49), AYA: 15.26 (unch), VSLR: 2.84 (+0.02), TRXC: 1.31 (+0.04), NYLD: 16.29 (+0.45), CHMA: 2.82 (-0.16)

Natus to Present at UBS Global Healthcare Conference
GlobeNewswire - Mon May 09, 6:00AM CDT
Natus Medical Incorporated (NASDAQ:BABY) today announced that Jonathan Kennedy, Sr. Vice-President and Chief Financial Officer, will present at the UBS Global Healthcare Conference in New York, NY. Mr. Kennedy is scheduled to present on Tuesday, May 24 at 10:00 a.m. Eastern Time (7:00 a.m. PT).
BABY: 40.44 (+0.79)

ATTENTION NATUS SHAREHOLDERS: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Natus Medical Incorporated; Encourages Investors to Contact the Firm for Additional Information
PR Newswire - Fri Apr 22, 8:30PM CDT
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Natus Medical Incorporated (NASDAQ: BABY) and certain of its officers. Natus designs, manufactures and markets newborn care and neurology healthcare products and services worldwide.
BABY: 40.44 (+0.79)

Hagens Berman Investigates Natus Medical Inc.'s Guidance on Prepayments From the Venezuelan Government and the Timing of Insider Sales
BusinessWire - Fri Apr 22, 7:30AM CDT
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, is investigating whether Natus Medical Incorporated. (NASDAQ: BABY) issued false and misleading statements about its expected receipt of prepayments under a contract with the Venezuelan Government and the timing of certain insiders' stock sales, potentially in violation of the securities laws.
BABY: 40.44 (+0.79)

Natus Medical Inc Says Adios to Venezuela Guidance
Brian Orelli, The Motley Fool - Motley Fool - Wed Apr 20, 3:05PM CDT
Natus Medical reported revenue of $87.3 million in the first quarter, just shy of the preliminary number of "approximately $87.5 million" that was disclosed earlier this month when the company said it wasn't going to hit its guidance. That's a...
BABY: 40.44 (+0.79)

Natus Medical beats 1Q profit forecasts
Automated Insights - Wed Apr 20, 5:11AM CDT
PLEASANTON, Calif. (AP) _ Natus Medical Inc. (BABY) on Wednesday reported first-quarter profit of $8.5 million.
BABY: 40.44 (+0.79)

Natus Medical Announces Record First Quarter 2016 Financial Results
GlobeNewswire - Wed Apr 20, 5:00AM CDT
-- Record first quarter non-GAAP earnings per share of $0.34
BABY: 40.44 (+0.79)

3 Things to Watch as Natus Medical Inc Reports Earnings
Brian Orelli, The Motley Fool - Motley Fool - Mon Apr 18, 3:15PM CDT
Image source: Natus Medical. Like the previous quarter, Natus Medical 's top-line results for the first quarter are going to be unsurprising when the company reports earnings on Wednesday since the revenue number was already disclosed . In...
BABY: 40.44 (+0.79)

NATUS NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Natus Medical Inc. to Contact the Firm
BusinessWire - Fri Apr 15, 7:18PM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Natus Medical Inc. ("Natus" or the "Company"

(NASDAQ:BABY).
BABY: 40.44 (+0.79)

IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against Natus Medical Inc. and Advises Investors with Losses to Contact the Firm
BusinessWire - Fri Apr 15, 4:02PM CDT
Goldberg Law PC (http://www.Goldberglawpc.com) announces that it is investigating claims of potential misrepresentations by Natus Medical Inc. ("Natus" or the "Company"

(Nasdaq: BABY). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.
BABY: 40.44 (+0.79)

INVESTOR ALERT: Investigation of Natus Medical Inc. Announced by Law Offices of Howard G. Smith
BusinessWire - Fri Apr 15, 12:13PM CDT
Law Offices of Howard G. Smith announces an investigation on behalf of investors of Natus Medical Inc. ("Natus" or the "Company"

(NASDAQ: BABY) concerning the Company and its officers' possible violations of federal securities laws. Law Offices of Howard G. Smith is preparing a lawsuit on behalf of injured investors.
BABY: 40.44 (+0.79)

Natus Medical: A Strong Sell on Weak Q1 & Estimate Revision
Zacks Equity Research - Zacks Investment Research - Thu Apr 07, 12:00PM CDT
On Apr 7, Zacks Investment Research downgraded Natus Medical Inc (BABY) to a Zacks Rank #5 (Strong Sell).
BABY: 40.44 (+0.79), GMED: 24.82 (-0.05), ARAY: 5.30 (+0.11), ANGO: 14.48 (-0.02)

Downgrade Alert for Natus Medical (BABY)
Comtex SmarTrend(R) - Wed Apr 06, 3:24AM CDT
Natus Medical (NASDAQ:BABY) was downgraded from Outperform to Market Perform at Raymond James today. The stock closed yesterday at $29.68 on volume of 1.8 million shares, above average daily volume of 322,000. Natus Medical Incorporated is a medical device company that develops, manufactures, and markets screening products. The Company's products identify and monitor common medical disorders that may occur between conception to a baby's first birthday. Natus is selling its ALGO products for newborn hearing screening, as well as its CO-Stat products for the evaluation of jaundice.
BABY: 40.44 (+0.79)

Company News for April 05, 2016
Zacks Equity Research - Zacks Investment Research - Tue Apr 05, 9:10AM CDT
Companies in the News are: VA,ALK,BABY,PHM,YHOO,TIME,SFTBF
TIME: 16.38 (+0.12), YHOO: 37.96 (+0.22), BABY: 40.44 (+0.79), VA: 56.22 (-0.04), PHM: 20.41 (-0.07), ALK: 60.16 (+0.30)

Virgin America and Edwards rise; Brocade, PulteGroup fall
AP - Mon Apr 04, 3:37PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq stock market:
BABY: 40.44 (+0.79), TSLA: 224.78 (+8.00), VA: 56.22 (-0.04), EW: 104.48 (-0.24), BRCD: 9.50 (+0.10)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Tomorrowland's Shanghai Return: An Electri-Lifesaver

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Antheia Secures $80M for Critical Medicine Onshoring

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

ASTS Faces a Legal Countdown – Investors Take Note

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...